Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LABTLakewood-Amedex Biotherapeutics Inc.

Nasdaq · CIK 0002079272
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts170

Identity from submissions API

NameLakewood-Amedex Biotherapeutics Inc.
CIK0002079272
TickersLABT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN205274304
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone9412252515
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
8031 COOPER CREEK BLVD.
SUITE 103
UNIVERSITY PARK
FL
34201
FL
Mailing address
8031 COOPER CREEK BLVD.
SUITE 103
UNIVERSITY PARK
FL
34201
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

47 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q QUARTERLY REPORT 0001213900-26-120790 001-43239 261562544 34 4611803 1 1
2026-11-16 8-K CURRENT REPORT 3.01,9.01 0001213900-26-120724 001-43239 261561962 34 194933 1 1
2026-11-10 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-26-118127 001-43239 261541601 34 235010 1 1
2026-09-29 8-K CURRENT REPORT 5.07 0001213900-26-104177 001-43239 261418498 34 208986 1 1
2026-09-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003056 333-299027 261406089 33 1800
2026-09-18 S-1 REGISTRATION STATEMENT 0001213900-26-101512 333-299027 261391827 33 11907599 1 1
2026-08-24 DRS filename1.htm 0001213900-26-092773 377-09702 261306215 33 3674839
2026-08-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-090808 333-292664 261287277 33 418665
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001174947-26-000808 005-95769 261281841 34 6335
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-089380 001-43239 261275723 34 4117173 1 1
2026-08-10 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-087338 001-43239 261259523 34 1754551
2026-08-10 DEF 14A PROXY STATEMENT 0001213900-26-087336 001-43239 261259513 34 4247857
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-086054 005-95769 261248196 34 6628
2026-07-30 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-083353 001-43239 261223849 34 1963334
2026-07-15 8-K CURRENT REPORT 7.01,9.01 0001213900-26-078328 001-43239 261177557 34 9426474 1 1
2026-06-23 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-070922 005-95769 261109672 34 6801
2026-06-22 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-070622 333-295497 261107156 33 26313
2026-06-22 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-070620 333-292664 261107111 33 26221
2026-06-17 8-K CURRENT REPORT 3.03,5.03,9.01 0001213900-26-069512 001-43239 261097099 34 1919924 1 1
2026-05-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-061019 333-292664 261019788 33 376067
2026-05-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-061018 333-295497 261019767 33 376098
2026-05-22 10-Q QUARTERLY REPORT 0001213900-26-060640 001-43239 261014805 34 3595179 1 1
2026-05-14 424B4 PROSPECTUS 0001213900-26-056648 333-295497 26979245 33 3097070
2026-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001622 333-295497 26975628 33 1799
2026-05-12 CORRESP filename1.htm 0001213900-26-054931 7921
2026-05-08 UPLOAD filename1.pdf 0000000000-26-004726 333-295497 153118
2026-05-06 4 4 0001193125-26-209581 5412
2026-05-06 3 3 0001193125-26-209578 3742
2026-05-01 3 xslF345X06/ownership.xml 0001213900-26-051078 9676
2026-05-01 3 xslF345X06/ownership.xml 0001213900-26-051054 7770
2026-05-01 3 xslF345X06/ownership.xml 0001213900-26-051053 8772
2026-05-01 3 xslF345X06/ownership.xml 0001213900-26-051052 8789
2026-05-01 S-1 REGISTRATION STATEMENT 0001213900-26-050936 333-295497 26932431 33 3408757 1 1
2026-04-30 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-050264 333-292664 26925783 33 41637
2026-04-28 8-K CURRENT REPORT 5.02,9.01 0001213900-26-048553 001-43239 26907993 34 336384 1 1
2026-04-23 424B4 PROSPECTUS 0001213900-26-047113 333-292664 26889362 33 13594803
2026-04-22 CERT LABT_8A_Cert_0002079272.pdf 0001354457-26-000363 001-43239 26884247 34 182473
2026-04-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001238 333-292664 26873225 33 1799
2026-04-17 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-26-045037 001-43239 26870833 34 16216
2026-04-06 S-1/A REGISTRATION STATEMENT 0001213900-26-040254 333-292664 26840034 33 13836562
2026-04-01 S-1/A REGISTRATION STATEMENT 0001213900-26-037938 333-292664 26824582 33 13768991
2026-03-11 S-1/A REGISTRATION STATEMENT 0001213900-26-026195 333-292664 26744092 33 13718865
2026-02-13 S-1/A REGISTRATION STATEMENT 0001213900-26-015814 333-292664 26628636 33 16425054
2026-02-05 S-1/A REGISTRATION STATEMENT 0001213900-26-012492 333-292664 26600183 33 45308502
2026-01-09 S-1 REGISTRATION STATEMENT 0001213900-26-003037 333-292664 26524081 33 22496934 1 1
2025-10-17 DRS/A filename1.htm 0001213900-25-100021 377-08278 251401480 33 15753137
2025-07-31 DRS filename1.htm 0001213900-25-070092 377-08278 251172809 33 13297494

Latest XBRL company facts

One latest value per concept from companyfacts (170 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.95M 2026-11-13 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
ffd NetFeeAmt NetFeeAmt USD 1,215.17 2026-09-16 S-1 2026-09-18 0001213900-26-101512
ffd TtlFeeAmt TtlFeeAmt USD 1,215.17 2026-09-16 S-1 2026-09-18 0001213900-26-101512
ffd TtlOfferingAmt TtlOfferingAmt USD 8.80M 2026-09-16 S-1 2026-09-18 0001213900-26-101512
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-16 S-1 2026-09-18 0001213900-26-101512
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-16 S-1 2026-09-18 0001213900-26-101512
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 361,460 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 240,397 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 66,521 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 68,179 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 73.19M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD -10.59M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 143,020 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 68,777 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 176,202 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 157,064 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap Assets Assets USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap AssetsCurrent Assets, Current USD 3.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 150,667 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CommonStockValue Common Stock, Value, Issued USD 366 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ContractualObligation Contractual Obligation USD 468,335 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 505,764 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ConvertibleDebt Convertible Debt USD 1.50M 2026-04-23 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 1.50M 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap CostMaintenance Cost, Maintenance USD 15,444 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 507,292 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-22 0001213900-26-060640
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 80 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 100,881 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 1.50M 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 697,905 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.38M 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 9.88M 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 883,261 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 101,337 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves USD 465,230 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 14.22M 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 19,967 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap Depreciation Depreciation USD 3,476 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 10.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-22 0001213900-26-060640
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.259 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.003 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.5 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.043 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.012 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 113,634 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 23.1 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -722 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2,409 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 996,005 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -808,004 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 29 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 11,914 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -165,448 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 47,091 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -140,644 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 57,588 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 46,438 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -88,908 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 121,679 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap InterestExpenseDebt Interest Expense, Debt USD 48,852 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 48,852 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2,409 2026-01-01 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 5,532 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 65,364 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap InvestmentIncomeNet Investment Income, Net USD 6.80M 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.1 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 2.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.028 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 71,932 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 41,179 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 41,179 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 30,753 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 499 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap Liabilities Liabilities USD 673,290 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap LiabilitiesCurrent Liabilities, Current USD 673,290 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -1.04M 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -6.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 6.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 17,112 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2026-01-01 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap OperatingExpenses Operating Expenses USD 6.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 71,433 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 71,433 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 41,035 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 70,234 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 88,618 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 7,821 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OtherExpenses Other Expenses USD 150,000 2026-04-21 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OtherIncome Other Income USD 600 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-22 0001213900-26-060640
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 600 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -13,636 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PaymentsForRent Payments for Rent USD 100,600 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 50,000 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1,846 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 1 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 619,228 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 185,447 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 6.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 697,905 2026-04-01 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 6.80M 2026-01-01 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 168,158 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 7.67M 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ProceedsFromSaleOfInvestmentProjects Proceeds from Sale of Investment Projects USD 585,198 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ProfessionalFees Professional Fees USD 75,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 77,404 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5,749 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap RealEstateTaxesAndInsurance Real Estate Taxes and Insurance USD 6,890 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -722 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 7.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-22 0001213900-26-060640
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 168,158 2026-01-01 2026-06-30 S-1 2026-09-18 0001213900-26-101512
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -70.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 6.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 176,202 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2026-04-24 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 23.1 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.088 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 107,989 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 24.01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 6,823 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 62,840 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 18.4 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 19.58 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 18.67 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 62,840 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 23.1 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 22.91 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 23.1 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap SharePrice Share Price USD/shares 23.1 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 8 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap ShortTermInvestments Short-term Investments USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.93M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockIssued1 Stock Issued USD 120,000 2025-01-01 2025-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 8.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.43M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.80M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.65M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockIssuedDuringPeriodValueStockDividend Stock Issued During Period, Value, Stock Dividend USD 10.59M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 50,000 2024-01-01 2024-12-31 S-1 2026-09-18 0001213900-26-101512
us-gaap TaxesOther Taxes, Other USD 7,552 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 4,787 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap TreasuryStockValue Treasury Stock, Value USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap VariableLeasePayment Variable Lease, Payment USD 7,198 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120790

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →